Onco 🧬 Flashcards

(105 cards)

1
Q

A 45 year-old female comes for annual physical examination. She has no known family history of breast cancer. Which is the correct advice on breast cancer screening?

a. Suggest self-examination from time to time
b. Suggest annual clinical examination
c. Provide the opportunity to start breast MRI with or without mammography annually
d. Do screening mammography annually

A

D. Choices A and B are wrong as these are not recommended by USPSTF or ACS. Choice C is not the best answer as patient is unlikely to have >20% lifetime risk of breast cancer (negative family history).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following is a correct method for screening for colorectal cancer among adults age 45 years or older?

a. Sigmoidoscopy every 10 years
b. CT colonography every 5 years
c. Colonoscopy every 5 years
d. Fecal immunochemical testing every 3 years

A

Answer is B. Choice A is wrong because sigmoidoscopy should be done every 5 years. Choice C is wrong because colonoscopy should be done every 10 years. Choice D is wrong because FIT testing should be done every year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A 25 year-old male came for 6-week history of aural fulness and otalgia. On physical examination, there are no palpable lymphadenopathies. On Craniocervical CT Scan, a 1.8 x 1.8 cm left nasopharyngeal mass was noted, with an enlarged 1.5 cm x 1.5 cm Level II lymph node on the left. What is the clinical stage of this patient?

a. Stage I
b. Stage II
c. Stage III
d. Stage IV

A

Answer is C. The nasopharyngeal mass is clinically T1, as it is less than 2 cm in dimension (another characteristic is depth of invasion <= 5 mm). However, the enlarged 1.5 cm Level II lymph node indicates N1 (<= 3 cm in greatest dimension). The presence of N1 automatically upstages the patient to Stage III.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A 35 year-old Filipino female developed a 3-month history of rapidly enlarging right breast mass. Biopsy revealed triple negative breast cancer. She then recalls that her sister also had ovarian cancer at age 40. Which drug may be beneficial for this patient?

a. Alpelisib
b. Glasdegib
c. Talazoparib
d. Trastuzumab

A

Answer is C. The presence of a strong family history of ovarian cancer and triple negative breast cancer (TNBC) suggest a germline BRCA1 or BRCA2 mutation. (Filipinos are also genetically predisposed to BRCA mutation.) PARP inhibitors such as olaparib and talazoparib have demonstrated benefit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A 70 year-old female came for 9-month history of gradually enlarging right breast mass. On physical examination, 3 cm x 3 cm hard firm breast mass located on the right upper outer quadrant. There are no noted cervical lymphadenopathies nor enlarged supraclavicular lymph node, but with (+) multiple (at least 3) palpable around 1.5 cm x 1.5 cm axillary lymphadenopathies, all mobile. No noted distant metastases. Core needle biopsy showed ER (+), PR (+), HER2 (-) What is the correct management for this patient?

a. Surgery only
b. Surgery with adjuvant hormonal therapy
c. Surgery with adjuvant hormonal therapy and cytotoxic chemotherapy
d. Surgery with adjuvant hormonal therapy, cytotoxic chemotherapy, and chest wall irradiation

A

Answer is D. The presence of 3 cm x 3 cm breast mass suggests T2. The presence of at least 3 palpable mobile lymphadenopathies suggests N1 (as opposed to fixed lymphadenopathies - N2). This is clinical Stage IIB (T2N1M0). The presence of hormone positivity means that adjuvant hormonal therapy is of benefit. Postmastectomy chest wall and regional nodal radiation reduces locoregional recurrence and improves survival. It is indicated for patients with high risk of locoregional recurrence, such as those with tumors ≥ 5 cm, four or more positive axillary lymph nodes, or postoperative positive margins. Postmastectomy radiation is not indicated in women with cancers < 2 cm, negative lymph nodes, and negative margins. It is considered for women who fall into the areas between these (2–5 cm, one to three positive nodes, or close margins) and is usually recommended if a patient has one to three involved axillary lymph nodes. (Taking into account more recent studies, these patients would also benefit from adjuvant CDK4/6 inhibitors such as ribociclib and abemaciclib.)
HPIM Ch79 p618

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What determines the staging of esophageal cancer?

a. Depth of invasion
b. Ki67 index
c. Tumor size
d. Tumor morphology

A

Answer is A. The depth of invasion primarily affects the tumor stage. Tis - high grade dysplasia; T1a - lamina propria, basement membrane, up to muscularis mucosae; T1b - submucosa; T2 - muscularis propria; T3 - adventitia; T4a - pleura; T4b - aorta. Ki67 is a measure of how actively cells are dividing in breast cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which of the following is/are appropriate post-operative surveillance methods for colorectal cancer patients following recovery from a complete resection?

a. CEA every 3 months
b. Completion colonoscopy within first several post-op months if not yet done pre-op
c. Annual CT scan for the first 3 post-op years
d. All of the above

A

Answer is D. “Following recovery from a complete resection, patients should be observed carefully for 5 years by semiannual physical examinations and blood chemistry measurements. If a complete colonoscopy was not performed preoperatively, it should be carried out within the first several postoperative months. Some authorities favor measuring plasma CEA levels at 3-month intervals because of the sensitivity of this test as a marker for otherwise undetectable tumor recurrence.” … “The value of periodic CT scans of the abdomen, assessing for an early, asymptomatic indication of tumor recurrence, while uncertain, has been recommended annually for the first 3 postoperative years.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which of the following is/are true about systemic chemotherapy and radiotherapy in colorectal cancer?

a. FOLFOX is more efficacious than FOLFIRI
b. Chemoradiation reduces recurrence but does not prolong survival
c. Leucovorin enhances efficacy of 5-FU
d. All of the above

A

Answer is C. “Radiation therapy, either administered pre- or postoperatively, further reduces the likelihood of pelvic recurrences
but does not appear to prolong survival. Combining radiation therapy with 5-fluorouracil (5-FU)-based chemotherapy, preferably prior to surgical resection, lowers local recurrence rates and improves overall survival. Radiation therapy alone is not effective as the primary treatment of colon cancer. Systemic therapy for patients with colorectal cancer has become more effective. 5-FU remains the backbone of treatment for this disease. The concomitant administration of folinic acid (leucovorin [LV]) improves the efficacy of 5-FU in patients with advanced colorectal cancer, presumably by enhancing the binding of 5-FU to its target enzyme, thymidylate synthase. FOLFIRI and FOLFOX are equal in efficacy.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A 45 year-old male with known history of HBV infection and chronic alcoholism presented with 4-month history of jaundice, abdominal enlargement, anorexia, unintentional weight loss. On physical examination, patient is alert, oriented, not in distress, with (+) icteric sclerae, pale palpebral conjunctivae, clear breath sounds. Notable is a distended abdomen, (+) caput medusae, (+) fluid wave. Labs showed INR 2.0, biliubin 2.5 mg/dL, albumin 29. He then underwent triphasic CT scan which showed vascular uptake in arterial phase with washout in the portal venous and delayed phases. What is the treatment of choice for this patient?

a. Resection or ablation, possible transplantation
b. Trans-arterial chemoembolization (TACE)
c. Combination Atezolizumab + Bevacizumab
d. Best supportive care

A

Answer is D. The findings of vascular uptake in arterial phase with washout in the portal venous and delayed phases is the biologic hallmark of hepatocellular carcinoma (HCCA). Before treatment, the Barcelona Clinic Liver Cancer (BCLC) staging criteria first assesses the Child-Pugh score of the patient. Patient’s Child-Pugh Score is as follows: 2 (albumin 29) + 2 (bilirubin 2.5) + 2 (INR 2.0) + 2 (fluid wave, moderate ascites) + 1 (no encephalopathy), leading to ta total of 10 points. This is Child-Pugh Class C, which corresponds to BCLC Stage D. At this point, none of the treatments are of benefit.
HPIM Ch82 F82-2, F82-3 p646-647

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the median overall survival of patients with resectable pancreatic cancer?

a. 6 - 10 months
b. 8.3 - 12.8 months
c. 18 - 23 months
d. More than 24 months

A

Answer is C. Choice A is for locally advanced disease, while choice B is for metastatic disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Stauffer’s Syndrome?

a. Superficial thrombophlebitis in patients with pancreatic cancer
b. Limb muscle weakness in patients with small cell lung cancer
c. Nonmetastatic hepatic dysfunction in patients with renal cell carcinoma
d. Sudden onset fever and painful red skin lesions in patients with breast cancer

A

Answer is C. Choice A refers to Trosseau Syndrome. Choice B refers to Lambert-Eaton Myasthenic Syndrome. Choice D refers to Sweet Syndrome.
HPIM Ch85 p674

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A prostate cancer that has invaded the bladder wall is assigned as…

a. T3
b. T4
c. N1
d. M1

A

Answer is B. T3 indicates tumor beyond prostate capsule. T4 indicates spread to adjacent organs. N1 indicates spread to regional lymph nodes. M1 metastasis to distant organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which cytotoxic chemotherapeutic agent can cause ataxia?

a. Cyclophosphamide
b. Cytarabine
c. Doxorubicin
d. Methotrexate

A

Answer is B. Cyclophosphamide has an adverse effect of Hemorrhagic Cystitis, Congestive Heart Failure. Doxorubicin has an adverse effect of Congestive Heart failure, Secondary Malignancies. Methotrexate has an adverse effect of Pneumonitis.
HPIM Ch95 T95-2 p738
The correct answer is: Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In critically ill patients to be started on PPI prophylaxis against stress-related gastric mucosal injury, which of the following scenarios would benefit due to high risk of bleeding?

a. A 65 y/o male smoker on Norepinephrine for septic shock secondary to pneumonia on day 3 of antibiotics
b. A 40 y/o obese female with Leptospirosis started on initiation dialysis and thrombocytopenia (Platelet count 40)
c. A 60 y/o male on Nitroglycerin drip for hypertensive emergency noted to be low dose aspirin for at least a year for ischemic heart disease
d. An 80 y/o female with chronic cerebrovascular infarct and prior tracheostomy admitted for sepsis due to infected sacral ulcer

A

B. A 40 y/o obese female with Leptospirosis started on initiation dialysis and thrombocytopenia (Platelet count 40)

The incidence of bleeding from stress-related gastric mucosal injury has decreased dramatically in recent years, most likely due to better care of critically ill patients. A guideline
suggested PPI prophylaxis in critically ill patients at high risk (≥4%) of bleeding, defined as mechanical ventilation without enteral nutrition,portal hypertension, cirrhosis, platelets <50 × 109/L, international normalized ratio >1.5,

OR two of the following: mechanical ventilation with enteral nutrition, acute kidney injury, sepsis, or shock.

HPIM 21st Ch48 p312

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In a 38 y/o female with chronic NSAID use for dysmenorrhea, new-onset hematochezia which of the following steps in management is correct?

a. If presenting with hemodynamic instability with no identified source of bleeding post EGD, an abdominal CT scan is warranted
b. If with no signs of hemodynamic instability and no identified site of bleeding on colonoscopy, do CT enterography
c. If with no signs of hemodynamic instability and no identified site of bleeding on colonoscopy, do capsule endoscopy
d. If with no signs of hemodynamic instability but bleeding persists despite identifying site post colonoscopy, abdominal CT scan is warranted

A

C. If with no signs of hemodynamic instability and no identified site of bleeding on colonoscopy, do capsule endoscopy

In patients suspected with small intestinal bleeding, video capsule endoscopy is the next diagnostic step that may be done or repeat upper and lower endoscopy. Systematic reviews report a diagnostic yield with capsule endoscopy of ~55%. Limitations of capsule endoscopy include the inability to fully visualize the small intestinal mucosa, sample tissue, or apply therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Carotenoderma is one of the differential diagnoses considered for yellowing of the skin. The following medications/conditions are associated with Carotenoderma except:

a. Sweet potatoes
b. Anorexia nervosa
c. Diabetes
d. Tobramycin

A

D. Tobramycin

Carotenoderma, a yellow coloring of the skin, is associated with diabetes, hypothyroidism, and anorexia nervosa, but most commonly, it is caused by the ingestion of an excessive amount of vegetables and fruits such as carrots, leafy vegetables, squash, peaches, and oranges that contain carotene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

A 31 y/o female coming in for persistent jaundice with no associated fever and abdominal pain had the following laboratory tests done: AST 88 ALT 124 ALP 525, nondilated biliary ducts on ultrasound and positive AMA. Which of the following is the next best step in management?

a. MRCP
b. Ceruloplasmin levels
c. Refer to hematology for bone marrow aspiration
d. Liver biopsy

A

D. Liver biopsy
Results show an obstructive type of jaundice (ALP elevation more than transaminases), and an intrahepatic cholestasis given the absence of biliary dilation.
AMA positivity may suggest primary biliary cholangitis. However, diagnosis of intrahepatic cholestasis is made with serologies AND liver biopsy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

C.C, a 35 y/o male, consulted at your clinic regarding cancer screening procedures. He is worried about the possibility of getting colorectal cancer as his father was diagnosed at age 70. He denies any constitutional symptoms as well as gastrointestinal complaints during his consultation. As an internist, you recommend:

a. Stool FIT every year with flexible sigmoidoscopy every 10 years beginning age 45
b. Flexible sigmoidoscopy every 5 years beginning age 40
c. Selective screening indicated only
d. Colonoscopy every 3-5 years beginning 10 years before the age of diagnosis

A

B. Flexible sigmoidoscopy every 5 years beginning age 40

Cancer screening for patients with first degree relatives diagnosed with CRC above 60 years recommend starting at age 40 with intervals similar to average risk recommendations

Choice A is part of the recommendations for average risk patients between 45-75 years of age.
Choice C is only recommended screening strategy for asymptomatic individuals >75 years of age.
Choice D is recommended for those diagnosed with Family colon cancer syndrome X

HPIM 21st Ch322 p2422 Table 322-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A 48 year old obese male consulted at your clinic due to regurgitation and symptoms of heartburn. He also notes sleep interruption due to excessive snoring, sometimes associated as well with heartburn. He states that this was partially reduced after elevated head rest and asks regarding other interventions. You recommend weight reduction and trial of medications. Which of the following drugs have the most efficacious profile?

a. Vonoprozan
b. Esomeprazole
c. Ranitidine
d. Rebampide

A

A. Vonoprozan

Pharmacologically reducing the acidity of gastric juice does not prevent reflux, but it ameliorates reflux symptoms and allows esophagitis to heal. The hierarchy of effectiveness among pharmaceuticals for healing esophagitis parallels their antisecretory potency. Potassium competitive acid blockers (PCABs) are more efficacious than proton pump inhibitors (PPIs), which are more efficacious than histamine-2 receptor antagonists (H2RAs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

If antibiotic susceptibility is not available, which of the following sequences in the empiric treatment of H. pylori is correct for patients in regions with low clarithromycin resistance rates?

a. Bismuth 4 drug -> Levofloxacin 3 drug -> Rifabutin 3 drug -> Clarithromycin 3 drug
b. Bismuth 4 drug -> Levofloxacin 3 drug -> Rifabutin 3 drug
c. Clarithromycin 3 drug -> Bismuth 4 drug -> Levofloxacin 3 drug -> Rifabutin 3 drug
d. Non-bismuth 4 drug -> Levofloxacin 3 drug -> Bismuth 4 drug -> Rifabutin 3 drug

A

C. Clarithromycin 3 drug -> Bismuth 4 drug -> Levofloxacin 3 drug -> Rifabutin 3 drug

Choice C is a correct sequence of escalation of treatment in H. pylori eradication for low clarithromycin resistance rates

Choice A is incorrect as Rifabutin is commonly the 4th line in low resistance rates. Choice B and D is incorrect as it is proposed for those with High clarithromycin rates or unknown resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

A 25 year old healthy male with no known comorbids consulted due to presence of blood in his stool. No associated abdominal pain, fever, diarrhea or vomiting. Upon examination, you noted protruding hemorrhoids requiring manual reduction. The following modes of treatment may be given except:

a. Short course of cortisone suppository
b. Fiber supplementation
c. Rubber band ligation
d. Infrared coagulation

A

D. Infrared coagulation

Table 339-6 in HPIM 22nd Ch339 summarizes the staging of hemorrhoids and their conventional treatment methods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

There is benefit in smoking cessation even after diagnosis of Lung CA

What is the FDA approved first line treatment?
Second line?

A

First line: antidepressant (bupropion) and nicotine replacement (varenicline)

Second line: clonidine and nortriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What neuroendocrine markers differentiate SCLC from NSCLC?

A

CD56
Neural cell adhesion molecule (NCAM)
Synaptophysin
Chromogranin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Lung CA types most commonly associated with tobacco use

A

Squamous and small cell CA

Smoker= Squamous & Small

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Most common form of lung CA in never smokers or former light smokers (<10 PY), women and young adults (<60years)?
Adenocarcinoma
26
Identify Lung CA type A) Nap-A +, TTF-1 + B) Nap A -, TTF-1 -, p40 +, p63+ C) Nap-A -, TTF-1 +
A) Adenocarcinoma B) Squamous CA C) Small cell
27
Screening bias: A) detecting the cancer earlier without an effect on survival B) indolent cancers are detected on screening and may not affect survival, whereas aggressive cancers are likely to cause symptoms earlier in patients and are less likely to be detected C) diagnosing cancers so slow growing that they are unlikely to cause the death of the patient
A) leaD time bias = Detecting B) lenGth-time bias = slow Growing more likely detected tha aGgressive C) overdiagnosis
28
Which lung CA type? A) hypercalcemia from ectopic production of PTH or PTH-related peptide B) Eaton-Lambert
A) Squamous cell B) Small cell
29
A 62-year-old man, chronic smoker, is diagnosed with non–small cell lung cancer (NSCLC). Imaging shows a right upper lobe mass with ipsilateral mediastinal lymphadenopathy. Which of the following findings would be a contraindication to potentially curative surgical resection? A. Tumor located 3 cm from the carina without nodal disease B. Ipsilateral mediastinal lymph node involvement (N2) C. Malignant pleural effusion on thoracentesis D. Phrenic nerve paralysis causing unilateral diaphragmatic elevation
C. Malignant pleural effusion Contraindications to curative resection in NSCLC: NO CURE SPRED •N – N3 nodes (contralateral mediastinal / supraclavicular) •O – Opposite lung metastasis •C – Carinal tumor (<2 cm) •U – Unresectable vessel (main pulmonary artery) •R – Recurrent laryngeal nerve paralysis •E – Effusion (malignant pleural) •S – SVC syndrome •P – Phrenic nerve paralysis •R – Remote (extrathoracic) metastases •E – External cardiac compression (tamponade) •D – Distant disease
30
A left lung tumor with ipsilateral mediastinal nodes. No distant disease. Stage? A. Stage II B. Stage IIIA C. Stage IIIB D. Stage IV
Answer: B – Stage IIIA 🔑 Cue: Ipsilateral mediastinal = N2 TX: No surgery, combined chemoradiotherapy follwed by durvalumab LUNG CANCER STAGING (HARRISON / AJCC 8th ed) ONE CORE MEMORY AID “3–5–7 | Near–Mid–Cross | Effusion = IV” ⸻ T = TUMOR (SIZE + INVASION) “3–5–7 RULE” (must memorize) • T1: ≤ 3 cm • T1a ≤1 cm • T1b >1–2 cm • T1c >2–3 cm • T2: >3–7 cm • T2a >3–5 cm • T2b >5–7 cm • OR visceral pleura, main bronchus ≥2 cm from carina, partial atelectasis • T3: >7 cm OR same-side extension • Chest wall, diaphragm • Phrenic nerve • Main bronchus <2 cm from carina • Same-lobe satellite nodules • T4: CENTRAL / CRITICAL • Mediastinum, heart, great vessels • Carina • Trachea, esophagus • Recurrent laryngeal nerve • Vertebral body • Different ipsilateral lobe nodules 👉 Mnemonic: “>7 or CORE = T3/T4” ⸻ N = NODES (SIDE MATTERS MORE THAN SIZE) “Near → Mid → Cross” • N0 – none • N1 – Ipsilateral hilar / peribronchial • N2 – Ipsilateral mediastinal / subcarinal • N3 – Contralateral mediastinal OR supraclavicular 👉 Mnemonic: “Crossed midline = N3” ⸻ M = METASTASIS (THIS OVERRIDES EVERYTHING) • M0 – none • M1a – Same chest • Malignant pleural or pericardial effusion • Contralateral lung nodules • M1b – Single extrathoracic metastasis • M1c – Multiple extrathoracic metastases 👉 Mnemonic: “EFFUSION = METS” ⸻ STAGE GROUPINGS – BOARD SHORTCUT Stage I • T1–T2a, N0 Stage II • T2b N0 OR any T1–T2 with N1 Stage III (NO SURGERY ZONE) • IIIA: N2 or T3 • IIIB: N3 or T4 📌 This is where PSBIM traps live Stage IV • ANY T, ANY N, M1 👉 Pleural effusion alone = Stage IV
31
A 64-year-old smoker has a 2.8-cm right upper lobe NSCLC. No lymphadenopathy and no distant metastases. Best management? A. Definitive chemoradiotherapy B. Surgery alone C. Surgery plus adjuvant chemotherapy D. Systemic therapy
Answer: B 🔑 Cue: T1 N0 → Stage I → surgery alone If <4cm, no nodes, surgery alone
32
A 5.8-cm lung mass with ipsilateral hilar lymph node involvement. No distant disease. Best treatment? A. Surgery alone B. Surgery plus adjuvant chemotherapy C. Definitive chemoradiotherapy D. Systemic therapy
Answer: B 🔑 Cue: T2b N1 → Stage II → surgery then adjuvant
33
Physiological testing and type of surgery A) FEV1 >2L or >80% PEF B) FEV1 >1.5L C) CPET VO2 <15ml
A) Pneumonectomy B) Lobectomy C) higher post operative risk
34
Contraindications to thoracic surgery
MI within past 3 months Uncontrolled arrhythmias FEV1 <1L PCO2 >45 DLCO2 <40%
35
two radiographic criteria are thought to predict the benign nature of a solitary pulmonary nodule:
lack of growth over a period >2 years; and characteristic patterns of calcification: dense central nidus, multiple punctuate foci, and “bull’s eye” (granuloma) and “popcorn ball” (hamartoma) calcifications are highly suggestive of a benign lesion
36
Based on the risk of malignancy, which of the following patients fits the INTERMEDIATE-RISK category? A. 42-year-old woman, never smoker, with a 1.2-cm smooth pulmonary nodule; quit smoking 10 years ago B. 55-year-old man, current smoker (15 cigarettes/day), with a 1.8-cm pulmonary nodule with scalloped margins; quit smoking 5 years ago C. 68-year-old man, current smoker (25 cigarettes/day), with a 2.6-cm spiculated pulmonary nodule; never quit smoking D. 40-year-old man, never smoker, with a 1.0-cm smooth pulmonary nodule; no smoking history
B. 55-year-old man, current smoker (15 cigarettes/day), with a 1.8-cm pulmonary nodule with scalloped margins; quit smoking 5 years ago
37
What is the treatment with curative intent for patients with isolated NSCLC pulmonary nodules (
Stereotactic body radiation therapy
38
All patients with resected NSCLC are at high risk of developing a second primary lung cancer or recurrence, most of which occur within 18–24 months of surgery When should periodic imaging be done?
Contrast chest CT every 6 months for the first 3 years after surgery followed by yearly CT scans without contrast
39
A 62-year-old man is diagnosed with small-cell lung cancer (SCLC). Complete staging workup shows no symptoms, signs, or imaging evidence of metastatic disease. His ECOG performance status is good, and he has no contraindication to combined chemoradiation. What is the best initial treatment? A. Platinum-based chemotherapy alone B. Sequential chemotherapy followed by radiation C. Combined chemotherapy and radiation therapy D. Chemotherapy with immunotherapy for palliation
C. Combined chemotherapy and radiation therapy • No metastatic disease → Limited-stage SCLC • Fit for treatment → Concurrent chemoradiation • Standard regimen: Platinum (cisplatin or carboplatin) + etoposide + thoracic radiation
40
Increases risk of developing breast cancer A) Late menarche (>12 years) B) Late first full term pregnancy (>35 yrs) C) no hormone replacement D) No functioning ovaries/ early menopause
B) Late first full term pregnancy (>35 yrs) Risk of developing breast cancer is higher in women with EARLY menarche (<12 years) and late first fullterm pregnancy (>35 years), and it is increased by exogenous hormone replacement therapy Women without functioning ovaries, who experience an early menopause, or who never receive combination estrogen/ progesterone replacement therapy are much less likely to develop breast cancer than those who have a normal menstrual history. Also, duration of maternal nursing correlates with substantial risk reduction independent of either parity or age at first full-term pregnancy
41
BRCA1 vs BRCA2 A) almost exclusively triple negative B) more likely to be ER + C) much higher in men who develop breast CA
A) BRCA1 B) BRCA2 C) BRCA2
42
Who should be tested for genetic mutation in breast CA?
- <40 y.o with triple negative breast CA - synchronous (<6 mos) or metachronous (>6 mos) contralateral breast CA - personal hx of ovarian CA - First degree relative with breast or ovarian CA - all males with breast CA
43
In premenopausal women, when should breast lesions that are either equivocal or nonsuspicious on physical examination be reexamined?
2-4 weeks during the follicular phase of the menstrual cycle *Days 5-7 of the cycle best time
44
Breast CA Intrinsic subtypes A) highest ER, negative or low HER2 B) ER +, pgR -, may express low HER2 C) exhibit co-amplification and overexpression of genes adjacent to HER2 D) triple negative
A) Luminal A B) Luminal B C) HER2-amplified D) Basal
45
Contraindications for breast-preserving therapy
- Large tumor to breast ratio - inability to achieve clear margins with adequate cosmesis - multifocal - 4 quadrant DCIS - inability to receive radiation (ex SLE)
46
When is post mastectomy radiation indicated?
Cancer 2–5 cm, one to three positive nodes, or close margins) and is usually recommended if a patient has one to three involved axillary lymph nodes
47
Breast CA A) Most important prognostic variable B) Most important predictive factors
A) TNM B) ER and HER2 expression
48
Standard duration of adjuvant endocrine treatment
5 years *may extend to 10 years
49
Breast CA Adjuvant therapy A) SERM for premenopausal women B) GnRH superagonist C) should not be administered to women with functioning, or dormant, ovaries, since the negative hypothalamic-pituitary feedback can result in a rebound overproduction of ovarian estrogens
A) Tamoxifen, toremifene B) goserelin or leuprolide C) Anastrazole, letrozole, exemestane (more effective than tamoxifen)
50
What is the major dose-limiting and life-changing toxicity of taxanes?
Peripheral neuropathy
51
Main toxicity of trastuzumab?
Cardiac dysfunction *do not give concurrently with anthracyclines *serial echo every 3 months
52
The likelihood of any polypoid lesion being cancerous Negligible? Intermediate? Substantial?
Negligible <1.5cm Intermediate 1.5-2.5cm Substantial >2.5cm
53
Risk factors Upper GI CA Squamous cell CA Adenocarcinoma
Squamous: Alcohol and tobacco, nitrates, hot tea, lye, radiation induced strictures, dietary deficiencies Adenocarcinoma: chronic GERD, obesity, Barrett’s esophagus, Male sex, cigarette
54
soft tissue and bony tumors, congenital hypertrophy of the retinal pigment epithelium, mesenteric desmoid tumors, and ampullary cancers in addition to the colonic polyps
Gardner’s syndrome
55
The appearance of malignant tumors of the central nervous system accompanying polyposis coli defines
Turcot’s syndrome
56
Increased incidence of large bowel cancer in IBD (esp UC). Which IBD patients should have surgical removal of the colon to significantly reduce the risk for cancer and eliminate the target organ for the underlying chronic GI disorder?
History of IBD lasting 15 years and more who continue to experience ecxacerbations
57
The most effective class of chemopreventive agent in colorectal CA? Other primary prevention agents?
Aspirin and NSAIDs Vitamin D and estrogen
58
Locations of lesions in colorectal CA A) lesions ulcerate, leading to chronic, insidious blood loss without change in stool B) presents with fatigue, palpitations and even angina with hypochromic, microcytuc anemia C) abdominal cramping, obstruction and perforation D) associated with hematochezia, tenesmus and narrowing of stool caliber
A) right colon B) ascending colon C) transverse and descending colon D) rectosigmoid Left colon tumors better prognosis than right *Abdominal xray may reveal annular, constricting lesion (apple-core or napkin-ring)
59
Prognosis in colorectal CA is related to depth of tumor penetration into the bowel Define: Stage I Stage II Stage III Stage IV
Stage I- no node, do not penetrate submucosa or muscularis Stage II- penetrate msucularis but no node Stage III- regional lymph node involvement Stage IV- metastatic spread
60
The liver is the most frequent site of mets for colorectal CA. It rarely spreads to the lungs, supraclavicular nodes, bone,or brain without prior liver mets. Exemption is tumor in distal rectum which pass through _______
Paravertebral venous pplexus (Batson’s plexus)
61
What are predictors of poorer outcomes following resection of colorectal CA? A. Well differentiated hsitology B. Preop CEA <5ng/ml C. Absence of b-raf gene D. Venous invasion
D. Venous invasion
62
Radiation therapy to the pelvis is recommended for patients with rectal CA following complete surgical resection of what stage?
Stage II or III especially if penetrated through serosa *Radiation alone is not effective as primary treatment
63
How does concomitant administration of folinic acid (leucoverin) improve the efficacy of 5-FU?
Enhancing the binding of 5-FU to thymidylate synthase
64
patient with nasopharyngeal carcinoma is due to receive cisplatin with concurrent radiation. What combination of anti-emetics would be appropriate before her due treatment? (HPIM21 P488) a. Ondansetron 8 mg IV + dexamethasone 20 mg IV + aprepitant PO b. Prochlorperazine 10 mg PO + dexamethasone 10 mg IV c. Olanzapine 10 mg PO + metoclopramide 10 mg IV d. Ondansetron 8 mg PO every 6 hours
A. Ondansetron 8 mg IV + dexamethasone 20 mg IV + aprepitant PO
65
Which of the following statements describes the mechanism of action of cyclophosphamide accurately? (HPIM21 P542) a. It forms covalent bonds with DNA bases, leading to cross-linkage of DNA strands b. It nterferes with purine synthesis, conveying the greatest toxicity to cells in the S-phase. c. It creates double-stranded breaks through which another segment of DNA duplex passes before rejoining. d. It binds to DNA through the DNA minor groove eventually leading to the disruption of the FUS-CHOP transcription action.
a. It forms covalent bonds with DNA bases, leading to cross-linkage of DNA strands
66
After receiving 3 cycles of chemotherapy, a patient with metastatic breast cancer comes in for a PET scan. Her scan reveals a 20% decrease in the sum of the longest diameters of her tumors. What is the her tumor response to chemotherapy by RECIST criteria? (HPIM21 P487) a. Complete response b. Partial response c. Stable disease d. Progressive disease
C. Stable disease Complete response: complete disappearance of disease Partial response: >50% reduction in the sum of all perpendicular diameters OR 30% decrease in sums of longest diameters of lesion Progressive disease: any new lesion OR >25% in the sum of perpendicular diameters OR increase of 20% in sum of longest diameters Stable disease: tumor shrinkage or growth not meeting other criterias
67
Necrotizing encephalopathy is the most severe form of radiation injury and almost always is associated with concurrent use of which chemotherapeutic drug? (HPIM21 P741) a. 5-fluorouracil b. Capecitabine c. Gemcitabine d. Methotrexate
D. Methotrexate
68
A patient with pancreatic carcinoma is known to harbor a mutation in the homologous recombination repair pathway. After achieving stable disease on 16 weeks of platinum-based chemotherapy, which oral medication is recommended as maintenance treatment? (HPIM21 P551 T73-6) a. Niraparib b. Olaparib c. Rucaparib d. Talazoparib
B. Olaparib
69
Which specific genetic alteration is usually seen in etoposide-related acute myeloid leukemia? (HPIM21 P740) a. Chromosome 5 or 7 deletion b. Chromosome 11q23 translocation c. Chromosome T(14;18) translocation d. Chromosome T(15;17) translocation
b. Chromosome 11q23 translocation
70
For a patient who will undergo first line palliative chemotherapy for his metastatic lung adenocarcinoma, which chemotherapy agent will you combine with Cisplatin for improved survival? (HPIM21 P608-609) a. Gemcitabine b. Paclitaxel c. Pemetrexed d. Ramucirumab
C. Pemetrexed
71
Which germline mutation increases one’s risk of developing gastric signet ring cell adenocarcinoma? Patients with this inherited mutation can be considered for prophylactic gastrectomy. (HPIM21 P627) a. RHBDF2 b. CDH1 c. MMR d. BRCA2
b. CDH1
72
A patient presents with a large, localized gastric mass. Resection was done and histopathology reveals a spindle cell subtype, with a high mitotic count. Further testing reveals positivity for cKIT 11 mutation. Which post-operative treatment option is appropriate? (HPIM21 P635) a. Imatinib b. Octreotide c. Rituximab d. Sorafenib
a. Imatinib
73
Which adjuvant treatment for resected cholangiocarcinoma is reported to improve overall survival? (HPIM21 P655) a. Gemcitabine b. Gemcitabine-oxaliplatin c. Capecitabine d. Capecitabine-oxaliplatin
c. Capecitabine
74
Independent predictors of HCC development among patients with HBV infection
- family history of HCC - HbeAg positivity - high viral load - genotype C
75
Polymorphism strongly associated with fatty and alcoholic chronic liver disease and HCC occurrence
PNPLA3
76
In which patients is surveillance for HCC recommended?
- cirrhotic patients due to any cause - HCV related fibrosis (Metavir score 3) - chronic HBV infection and aged >40 if Asian, >20 if African - family history of HCC - sufficient risk scores such as PAGE-B **Not recommended in advanced cirrhosis (Child Pugh C)
77
What is the recommended method of surveillance in HCC?
Utz every 6 months with or without AFP *shorter follow up (every 3-4 months) if <1cm nodule detected **AFP is not a stand alone because high false positivity and only a small proportion of early tumors present with abnormal AFP
78
Radiologic diagnosis is achieved with a high degree of confidence if the lesion is >/=1 cm in diameter and shows the radiologic hallmarks of HCC What is the typical hallmark of HCC?
Vascular uptake of the nodule in the arterial phase with washout in the portal or delayed phases
79
What AFP levels are highly suspicious but not diagnostic of HCC
400 ng/dl and above
80
When is pathologic diagnosis required in hepatic nodules?
- non cirrhotic patients - imaging is not typical in at least 2 imaging techniques * A negative biopsy does not eliminate the diagnosis of HCC. A second biopsy is recommended in case of inconclusive findings or if growth or change in enhancement pattern is identified during follow-up
81
A 59-year-old man with chronic hepatitis B undergoes surveillance ultrasound that shows four hepatic nodules, each measuring 2.5 cm. He has no ascites or encephalopathy, ECOG performance status 0, and Child-Pugh class A liver disease. There is no vascular invasion or extrahepatic spread. What is the best initial management? A. Surgical resection B. Transarterial chemoembolization (TACE) C. Systemic therapy with atezolizumab plus bevacizumab D. Best supportive care
B. TACE
82
Classical risk factors for cholangiocarcinoma
PSC biliary duct cyst Hepatolithiasis Caroli’s disease Parasitic infections (Opistorchis viverrini and Clonorchis sinensis) HBV, HCV and cirrhosis
83
Chracteristic dynamic CT scan result for iCCA
liver mass-forming tumors with progressive contrast uptake from the arterial to the venous/delayed phase
84
Treatment in intrahepatic cholangiocarcinoma (iCCA) Stage I (single) and II (multinodular) Stage III (visceral peritoneum perforation, local hepatic invasion) Stage IV (periductal invasion)
Stage I and II- surgical resection possible adjuvant therapy with capecitabine x 6 mos Stage III- Locoreginal therapy or Gemcitabine+Cisplatin Stage IV- Gemcitabine+Cisplatin; if progression, FOLFOX
85
Ruling out what disease is mandatory in extrahepatic cholangiocarcinoma?
IgG4 cholangiopathy
86
What is the main risk factor in the development of hepatic adenomas?
Oral contraceptives in females and anabolic androgenic steroids in males
87
The greatest risk factor for pancreatitis?
Cigarette smoking
88
In pancreatic CA< which serum marker is requested when both CEA and Ca19-9 are both negative
CA125
89
PSA levels A) Cut off for biopsy in men 55-69 B) Current standard definition of biochemical failure (Phoenix definition) C) when should PSA be undetectable post prostatectomy
A) 4ng/ml and above B) rise by 2ng/ml and above than the lowest PSA C) within 6 weeks
90
Treatment? Non castrate metastatic disease: testosterone >150 ng/ml Castration resistant prostate cancer (CRPC): testosterone at 5 ng/ml
Testosterone loweing (GnRH agonist leuprolide/goserelin and antiandrogen bicalutamide or apalutamide, darolutamide, enzalutamide) Docetaxel plus newer antisandrogens apalutamide, darolutamide, enzalutamide
91
What healthful habit would save more lives than any other public health activity?
Smoking cessation and avoidance
92
BMI was linearly associated with many cancers but is inversely associated with?
Prostate and premenopausal breast cancer
93
What cancer is associated with exposure to this carcinogen? A) Aromatic amines B) Vinyl chloride C) Benzene
A) Bladder CA B) Liver angiosarcoma C) AML
94
Appears as red or bluish-red papules or nodules that may coalesce and form sharply bordered plaques commonly on face, neck, arms; characterized by presence of leukocytes in the lower dermis with edema of the papillary body
Sweet syndrome or Febrile neutrophilic dermatosis
95
In catheter infections in immunocompromised patients, which cases would catheter removal be recommended?
Tunneled catheter site erythema (-) blood culture Non CoNS Gram positive cocci and rods, gram neg bacteria, fungi
96
Which can present as a mass lesion in CNS infection in immunocompromised patients? a. JC virus b. CMV c. Nocardia d. Listeria
C. Nocardia Mass lesion: CANT Cryptococcus. Aspergillus, Nocardia, Toxoplasmosis
97
What agent/agents can be used for the treatment of patients with thymoma in the adjuvant setting, neoadjuvant setting or as first line therapy in metastatic disease? a. Pembrolizumab b. Paclitaxel – Carboplati c. Pemetrexed – Cisplatin d. Cisplatin – Doxorubicin - Cyclophosphamide
CDC Cisplatin-Doxorubicin-Cyclophosphamide
98
A patient with Barcelona C hepatocellular carcinoma is being prepared to receive bevacizumab-atezolizumab. Which procedure is required prior to starting the treatment? a. Intracardiac BP monitoring b. 24 hour urine protein c. Endoscopy d. Echocardiography
C. Endoscopy Bevacizumab can cause bleeding
99
A patient with advanced small cell lung carcinoma has been receiving targeted therapy together with chemotherapy for the past three months. She noted the following symptoms after her second cycle of the treatment: palpitations, diarrhea and intolerance to heat. Which agent needs to be temporarily held until these adverse events are tolerable? a. Carboplatin b. Paclitaxel c. Durvalumab d. Bevacizumab
C. Durvalumab Source: HPIM 21st ed. Ch 73 p.537 The symptoms describe hyperthyroidism which may be the initial presentation of thyroid dysfunction in patients receiving immunotherapy (anti-PD1, anti-PDL1, anti-CTLA4 agents or a combination of these). Durvalumab is a PDL1-inhibitor. Carboplatin, paclitaxel and bevacizumab do not cause autoimmune adverse events. *Mnemonic for Anti-PDL1 agents: Si ATEZ AVEr DUR, Lumalaban See Figure 5 in next section
100
While a patient with colorectal is getting his chemotherapy infusion, he suddenly develops laryngopharnygeal spasm. Which alkylating agent is the most likely cause for this adverse event? a. Cisplatin b. Cyclophosphamide c. Ifosfamide d. Oxaliplatin
Answer: D. Oxaliplatin Source: HPIM 21st ed. Ch 73 p.540 Among the platinums, it is best to remember their unique adverse events: Cisplatin - is known to cause ototoxicity and nephrotoxicity. It is also highly emetogenic. It is a must to maintain high urine flow by means of osmotic diuresis; monitoring intake, output and serum potassium and magnesium are also required. Carboplatin - tends to be more toxic to the marrow; less nephrotoxic since often given in reduced doses depending on creatinine clearance (dose is usually AUC of 5-7mg/ml/min) Oxaliplatin - more neurotoxic (chronic neurotoxicity is cumulative with dose); unique adverse event is laryngeopharyngeal spasm (often triggered by exposure to the cold - eg. drinking cold water; cold environment) The correct answer is: Oxaliplatin
101
A patient who received dose dense chemotherapy is on her 5th day of admission for febrile neutropenia and has received antibiotics for 3 days. Patient is currently afebrile and with no obvious site of infection identified. All scans and cultures have remained negative. Which of the following interventions is appropriate? a. Stop antibiotic treatment b. Continue current regimen c. Add an antiviral agent d. Add a broad-spectrum antifungal agent
Answer: A. Stop antibiotic treatment Source: HPIM 21st ed. Ch 74 p.563 Key points in empiric treatment of febrile neutropenia: Low risk patients with febrile neutropenia (expected neutropenia <10 days and have no concurrent medical problems) can be treated in the outpatient with broad spectrum oral regimen Choose broad spectrum (with activity against gram positive and gram negative bacteria) antibiotics for febrile patients in whom prolonged neutropenia (>7 days) is anticipated including: 1) ceftazidime or cefepime, 2) piperacillin tazobactam or 3) imipenem/cilastatin or meropenem. Adding amphotericin B or other newer azoles as empiric addition to treat patients who remain febrile despite 4-7 days of antibiotics is done because it is difficult to culture fungi before they cause disseminated disease. Recent analyses suggest that the efficacy against certain gram negative organisms when combining B lactams and aminoglycosides is not enhanced, while toxicity may be increased. Only judicious use of vancomycin is recommended - when there is good reason to suspect involvement of coagulase-negative staphylococci (eg. erythema at catheter-exit site or positive culture of mRSA and coagulase-negative staphylococci) Option B (Continue current regimen) may be correct. If the patient is already afebrile but the ANC (which is not specified in the question) is still very low, the patient may still be at high risk even if there is no identified focus of infection.
102
What stage of non-small cell lung cancer is a case of left lung primary with mediastinal invasion, multiple nodules in the right lung and biopsy-proven metastatic liver nodule? a. Stage IVA (T4N0M1a) b. Stage IVA (T4N0M1b) c. Stage IVB (T4N0M1b) d. Stage IVC (T4N0M1c)
Answer: B. Stage IVA (T4N0M1b) Source: HPIM 21st ed. Ch 78 p.601 T4 - tumor of any size invading the mediastinum (or heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina; or separate tumor nodules in a different IPSILATERAL lobe; if SAME IPSILATERAL lobe, that is T3) M1a - separate tumor nodules in CONTRALATERAL lobe, malignant pleural or pericardial effusion M1b - single metastasis to a single organ; M1c - multiple metastases to a single organ or metastasis to multiple organs Option D is automatically incorrect because there is no such thing as stage IVC lung cancer. M1a/b = stage IVA; M1c = stage IVB.
103
Which patient is a good candidate for definitive combined chemoradiation for small cell lung cancer? a. Left lung primary, hilar adenopathy and malignant pleural effusion b. Right lung primary with extension into the recurrent laryngeal nerve c. Right lung primary with massive malignant pericardial effusion d. Left lung primary with contralateral lung lesion
Answer: B. Right lung primary with extension into the recurrent laryngeal nerve Source: HPIM 21st ed. Ch 78 p.601, 609 Concurrent chemoradiation is the most effective regimen for small cell lung cancers that are confined to the ipsilateral hemithorax or can be encompassed within a tolerable radiation port. If there is unavailability or poor functionality, then sequential chemotherapy and radiation may be done. See Figure 19 in next section
104
Active surveillance is an appropriate intervention for patients with localized prostate cancer who are deemed “very low” or “low” risk. Which among the following is part of an active surveillance program for prostate cancer? a. PSA determination monthly b. Repeat prostate biopsy every 2- 5 years c. Bone Scan every three years d. PSMA PET Scan annually
Answer: B. Repeat prostate biopsy every 2- 5 years Source: HPIM 21st ed. Ch 87 p.686 An active surveillance plan involves PSA no more often than every 6 months, DRE no more often than every 12 months, Repeat prostate biopsy every 2-5 years, repeat mpMRI no more often than every 12 months. The correct answer is: Repeat prostate biopsy every 2- 5 years
105
In patients exposed to chest radiation at 22 years old, the guidelines for breast cancer surveillance with mammography and/or breast MRI is started at what age? a. 25 years old b. 30 years old c. 35 years old d. 40 years old 
Answer: B. 30 years old Source: HPIM 21st ed. Ch 95 p.743 Guidelines for breast cancer surveillance in survivors exposed to chest radiation recommend that patients be screened with mammograms and/or breast MRI beginning at age 25 years or 8 years after treatment, whichever occurs later. The correct answer is: 30 years old